Skip to main content

Table 1 The proportion of the HepG2 phase of G0/G1 cells and S in the total number of cells incubated with TGO, TGD and ox-TG

From: Comparison of different polar compounds-induced cytotoxicity in human hepatocellular carcinoma HepG2 cells

  Time (h) 24 48
Concentration (mg/mL) G0/G1 (%) S (%) G0/G1 (%) S (%)
Control 0.00 46.32 ± 1.69 41.05 ± 1.33 45.68 ± 0.61 41.67 ± 0.74
TGO 0.05 47.48 ± 1.41 38.93 ± 1.52 46.28 ± 0.15 43.47 ± 0.17
TGO 0.50 45.88 ± 0.64 44.74 ± 0.57 40.25 ± 0.83 49.37 ± 0.97
TGO 2.00 38.84 ± 0.18 49.42 ± 0.17 36.41 ± 0.24 54.54 ± 0.42
TGD 0.05 47.69 ± 1.59 42.95 ± 1.44 43.40 ± 0.56 42.96 ± 0.18
TGD 0.50 43.20 ± 0.10 47.62 ± 0.32 38.63 ± 0.78 50.00 ± 0.57
TGD 2.00 37.60 ± 0.08 50.49 ± 0.09 33.87 ± 0.85 57.68 ± 0.76
ox-TG 0.05 40.36 ± 1.35 49.42 ± 1.46 38.18 ± 0.32 50.49 ± 0.34
ox-TG 0.50 37.06 ± 0.63 49.69 ± 0.61 36.41 ± 0.79 51.55 ± 0.68
ox-TG 2.00 33.67 ± 0.27 54.92 ± 0.18 29.74 ± 0.35 57.60 ± 0.45